⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL13724415 | 0.96 | — | — | |
| SCHEMBL16970022 | 0.77 | — | — | |
| SCHEMBL16969958 | 0.74 | — | — | |
| SCHEMBL28023518 | 0.72 | LMNA (0.38) | — | |
| SCHEMBL28023557 | 0.72 | LMNA (0.38) | — | |
| SCHEMBL7584024 | 0.72 | — | — | |
| SCHEMBL2566427 | 0.71 | — | — | |
| SCHEMBL15978570 | 0.69 | — | — | |
| SCHEMBL10786782 | 0.69 | — | — | |
| SCHEMBL10874008 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200236932-A1 | POLYALCOHOL, CARBOHYDRATE, NUCLEOBASE AND NUCLEOTIDE COMPOSITIONS AND USES THEREOF | ZHANG, CHUNBO | 2020-07-30 | — | — | US | claimed |
| WO-2017053467-A1 | POLYALCOHOL, CARBOHYDRATE, NUCLEOBASE AND NUCLEOSIDE COMPOSITIONS AND USES THEREOF | COMBI-BLOCKS, INC. (US) | 2017-03-30 | — | — | WO | claimed |
| US-20250367232-A1 | HALOGEN TREATMENT OF HEART ATTACK AND ISCHEMIC INJURY | HUTCHINSON FRED CANCER RES (US) | 2025-12-04 | — | — | US | disclosed |
| US-12016880-B2 | Halogen treatment of heart attack and ischemic injury | FRED HUTCHINSON CANCER CENTER (US) | 2024-06-25 | — | — | US | disclosed |
| EP-3104939-B1 | TREATMENT OF HEART ATTACK AND ISCHEMIC INJURY WITH SODIUM IODIDE | FRED HUTCHINSON CANCER CENTER (US) | 2024-05-01 | — | — | EP | disclosed |
| US-20240099948-A1 | Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents | COLABS INT'L CORP. (US) | 2024-03-28 | — | — | US | disclosed |
| US-11839674-B2 | Compositions comprising silicon dioxide-based particles including one or more agents | CoLabs International Corporation (US) | 2023-12-12 | — | — | US | disclosed |
| US-11724134-B2 | Compositions containing a cellulose derived capsule with a sunscreen active agent | CoLabs International Corporation (US) | 2023-08-15 | — | — | US | disclosed |
| US-11707421-B2 | Compositions containing a flexible derived capsule with an active agent | COLABS INT'L CORP. (US) | 2023-07-25 | — | — | US | disclosed |
| US-20230113098-A1 | Compositions Containing a Capsule with an Agent | COLABS INT'L CORP. (US) | 2023-04-13 | — | — | US | disclosed |
| US-11553713-B2 | Polyalcohol, carbohydrate, nucleobase and nucleotide compositions and uses thereof | Zhang, Chunbo (US) | 2023-01-17 | — | — | US | disclosed |
| EP-2254574-A1 | BETA-LACTONES AS ANTIBACTERIAL AGENTS | Ludwig-Maximilians-Universität München (DE) | 2010-12-01 | — | — | EP | disclosed |
| WO-2009106211-A1 | BETA-LACTONES AS ANTIBACTERIAL AGENTS | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2009-09-03 | — | — | WO | disclosed |
| CN-1020605-C | PROCESS FOR PREPARING AZACYCLOPARAFFIN DERIVATIVES | HISAMITSU PHARMACEUTICAL CO (JP) | 1993-05-12 | — | — | CN | disclosed |
| CN-1019573-B | PROCESS FOR PREPARING NITROHETEROCYCLIC ALKANE DERIVATIVES | HISAMITSU PHARMACEUTICAL CO (JP) | 1992-12-23 | — | — | CN | disclosed |
| CN-1018452-B | PROCESS FOR PREPARING AZACYCLOALKANE DERIVATIVES | HISAMITSU PHARMACEUTICAL CO (JP) | 1992-09-30 | — | — | CN | disclosed |
| CN-1060465-A | Process for preparing azacycloalkane derivatives | HISAMITSU PHARMACEUTICAL CO (JP) | 1992-04-22 | — | — | CN | disclosed |
| CN-1060287-A | The method for preparing azacycloparaffin derivatives | HISAMITSU PHARMACEUTICAL CO (JP) | 1992-04-15 | — | — | CN | disclosed |
| CN-87100666-A | Nitrogen heterocyclic derivative, absorption enhancer containing the derivative as active ingredient, and external preparation containing the absorption enhancer | — | 1987-10-21 | — | — | CN | disclosed |
| EP-0091305-A2 | Method for producing vicinal, heterogeneous dihalogenated products, their use, and novel products | CETUS CORPORATION (US) | 1983-10-12 | — | — | EP | disclosed |